MARCHF4
Basic information
Region (hg38): 2:216257865-216372483
Previous symbols: [ "MARCH4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MARCHF4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 1 | 1 |
Variants in MARCHF4
This is a list of pathogenic ClinVar variants found in the MARCHF4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-216259316-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
2-216259317-C-G | not specified | Uncertain significance (Sep 07, 2022) | ||
2-216259367-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
2-216259491-C-T | not specified | Uncertain significance (Mar 07, 2023) | ||
2-216259530-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
2-216259563-C-T | not specified | Uncertain significance (May 16, 2024) | ||
2-216259574-T-C | not specified | Uncertain significance (Jan 04, 2022) | ||
2-216259646-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
2-216259654-C-T | Benign (May 24, 2018) | |||
2-216277675-T-G | not specified | Uncertain significance (Sep 29, 2022) | ||
2-216277705-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
2-216277743-C-A | not specified | Uncertain significance (Jan 24, 2023) | ||
2-216277789-C-T | not specified | Uncertain significance (May 09, 2023) | ||
2-216283615-T-C | Frontotemporal dementia | Uncertain significance (-) | ||
2-216369785-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
2-216369798-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
2-216369812-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
2-216369822-G-T | not specified | Uncertain significance (Jan 24, 2023) | ||
2-216369866-C-A | not specified | Uncertain significance (Feb 14, 2023) | ||
2-216369927-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
2-216369974-A-C | not specified | Likely benign (Dec 08, 2023) | ||
2-216370004-C-A | not specified | Uncertain significance (May 10, 2022) | ||
2-216370033-G-T | not specified | Uncertain significance (Oct 26, 2022) | ||
2-216370130-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
2-216370181-G-A | not specified | Uncertain significance (Nov 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MARCHF4 | protein_coding | protein_coding | ENST00000273067 | 4 | 114163 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.133 | 0.866 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 196 | 247 | 0.795 | 0.0000144 | 2628 |
Missense in Polyphen | 48 | 75.474 | 0.63598 | 800 | ||
Synonymous | -0.852 | 114 | 103 | 1.11 | 0.00000644 | 835 |
Loss of Function | 2.92 | 5 | 18.6 | 0.269 | 8.39e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000136 | 0.000132 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.000300 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that may mediate ubiquitination of MHC-I and CD4, and promote their subsequent endocytosis and sorting to lysosomes via multivesicular bodies. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin- conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. {ECO:0000269|PubMed:14722266}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.317
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- Y
- hipred_score
- 0.525
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.149
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- March4
- Phenotype
Gene ontology
- Biological process
- protein ubiquitination
- Cellular component
- Golgi membrane;Golgi stack;trans-Golgi network;integral component of membrane
- Molecular function
- ubiquitin-protein transferase activity;zinc ion binding